BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38701395)

  • 1. PHES scores have limited impact on the risk of overt HE in patients with minimal HE.
    Gairing SJ; Mangini C; Zarantonello L; Jonasson E; Danneberg S; Sultanik P; Galle PR; Gioia S; Labenz J; Lok AS; Marquardt JU; Lauridsen MM; Bloom PP; Thabut D; Nardelli S; Montagnese S; Labenz C
    Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38701395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
    Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
    Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
    Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
    J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
    Kircheis G; Hilger N; Häussinger D
    Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy.
    Duarte-Rojo A; Estradas J; Hernández-Ramos R; Ponce-de-León S; Córdoba J; Torre A
    Dig Dis Sci; 2011 Oct; 56(10):3014-23. PubMed ID: 21461913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing.
    Duarte-Rojo A; Allampati S; Thacker LR; Flud CR; Patidar KR; White MB; Klair JS; Heuman DM; Wade JB; Gavis EA; Bajaj JS
    Metab Brain Dis; 2019 Feb; 34(1):289-295. PubMed ID: 30506333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival.
    Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Lok AS; Sultanik P; Galle PR; Labenz J; Thabut D; Marquardt JU; Bloom PP; Lauridsen MM; Montagnese S; Nardelli S; Labenz C
    J Intern Med; 2024 Mar; 295(3):331-345. PubMed ID: 37983845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study.
    Huang CH; Yu TY; Tseng WJ; Huang YT; Chang SH; Hsieh SY; Chien RN; Amodio P
    Ann Med; 2023 Dec; 55(1):2236013. PubMed ID: 37494454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy.
    Riggio O; Ridola L; Pasquale C; Pentassuglio I; Nardelli S; Moscucci F; Merli M; Montagnese S; Amodio P; Merkel C
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):613-6.e1. PubMed ID: 21440091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver.
    Taneja S; Dhiman RK; Khatri A; Goyal S; Thumbru KK; Agarwal R; Duseja A; Chawla Y
    J Clin Exp Hepatol; 2012 Dec; 2(4):306-14. PubMed ID: 25755452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
    Umapathy S; Dhiman RK; Grover S; Duseja A; Chawla YK
    Am J Gastroenterol; 2014 Jul; 109(7):1011-9. PubMed ID: 24777152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.
    Bajaj JS; Thacker LR; Heuman DM; Fuchs M; Sterling RK; Sanyal AJ; Puri P; Siddiqui MS; Stravitz RT; Bouneva I; Luketic V; Noble N; White MB; Monteith P; Unser A; Wade JB
    Hepatology; 2013 Sep; 58(3):1122-32. PubMed ID: 23389962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis.
    Schleicher EM; Kaps L; Schattenberg JM; Galle PR; Wörns MA; Gairing SJ; Labenz C
    Dig Liver Dis; 2024 Jun; 56(6):1046-1053. PubMed ID: 38105147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study.
    Allampati S; Duarte-Rojo A; Thacker LR; Patidar KR; White MB; Klair JS; John B; Heuman DM; Wade JB; Flud C; O'Shea R; Gavis EA; Unser AB; Bajaj JS
    Am J Gastroenterol; 2016 Jan; 111(1):78-86. PubMed ID: 26644276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study.
    Wunsch E; Koziarska D; Kotarska K; Nowacki P; Milkiewicz P
    Liver Int; 2013 Oct; 33(9):1332-40. PubMed ID: 23651263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive reserve is a resilience factor for cognitive dysfunction in hepatic encephalopathy.
    Amodio P; Montagnese S; Spinelli G; Schiff S; Mapelli D
    Metab Brain Dis; 2017 Aug; 32(4):1287-1293. PubMed ID: 28573602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.
    Wernberg CW; Schaffalitzky de Muckadell OB; Vilstrup H; M Lauridsen M
    PLoS One; 2019; 14(12):e0226283. PubMed ID: 31830113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.